Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Sanofi and GSK collaborate to develop an adjuvanted vaccine for COVID-19

April 15, 2020

Moderna reports interim phase I data for mRNA-1893 vaccine

April 15, 2020

AstraZeneca initiates CALAVI study of Calquence against COVID-19

April 15, 2020

The next pandemic: fire breaks and host-directed therapies

April 15, 2020

Lilly advances plans to evaluate baricitinib and LY-3127804 for COVID-19

April 14, 2020

Bausch Health initiates clinical trial of Virazole in patients with COVID-19

April 14, 2020

Ridgeback Biotherapeutics initiates phase I study of EIDD-2801 for COVID-19

April 14, 2020

New small-molecule inhibitor of enterovirus 71 for the treatment of hand, foot and mouth disease

April 14, 2020

Death, taxes and zoonotic spillover

April 14, 2020

CSL Behring and SAB partner on development of COVID-19 therapeutic candidate SAB-185

April 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....